The Mixed Lineage Leukemia (MLL1, KMT2A) gene is critical for development and maintenance of hematopoietic stem cells (HSCs), however, whether this protein is limiting for HSC development is unknown due to lack of physiologic model systems. Here, we develop an MLL1-inducible embryonic stem cell (ESC) system and show that induction of wild-type MLL1 during ESC differentiation selectively increases hematopoietic potential from a transitional c-Kit + /Cd41 + population in the embryoid body and also at sites of hematopoiesis in embryos. Single-cell sequencing analysis illustrates inherent heterogeneity of the c-Kit + /Cd41 + population and demonstrates that MLL1 induction shifts its composition toward multilineage hematopoietic identities. Surprisingly, this does not occur through increasing Hox or other canonical MLL1 targets but through an enhanced Rac/Rho/ integrin signaling state, which increases responsiveness to Vla4 ligands and enhances hematopoietic commitment. Together, our data implicate a Rac/Rho/integrin signaling axis in the endothelial to hematopoietic transition and demonstrate that MLL1 actives this axis.
INTRODUCTION
Studying embryonic stem cell (ESC) differentiation in vitro has contributed to understanding early developmental processes while identifying methods to direct differentiation of specific cell types potentially useful to treat a variety of pathophysiologic conditions (Keller, 2005) . Despite remarkable progress made over two decades, it is not yet feasible to produce hematopoietic stem and progenitor cells (HSPCs) from ESCs that engraft and persist in recipients (Ditadi et al., 2017; Rowe et al., 2016) . In vertebrates, hematopoiesis occurs in successive waves, producing diverse progenitors with specific potentials (Dzierzak and Bigas, 2018; Dzierzak and Speck, 2008) . The first wave is initiated in the yolk sac (YS) blood islands and gives rise to a transient population of primitive red blood cells, diploid megakaryocytes, and primitive macrophages (Bertrand et al., 2005; Palis et al., 1999; Tober et al., 2007) . A second wave initiating in the YS gives rise to definitive erythroid and myeloid progenitors (EMPs) (Lux et al., 2008; McGrath et al., 2015; Palis et al., 1999) . A third wave occurs at embryonic (E) day 10.5 in the major arteries: the dorsal aorta, vitelline artery, and umbilical artery of the aorta-gonad-mesonephros (AGM) region (Dzierzak and Speck, 2008) ; this is the first site at which transplantable hematopoietic stem cells (HSCs) are produced. These HSCs and the earlier multipotent progenitors are thought to arise from specialized endothelium (hemogenic endothelium [HE] ) through an endothelial to hematopoietic transition (EHT) (Bertrand et al., 2010; Boisset et al., 2010; Eilken et al., 2009; Frame et al., 2016; Lancrin et al., 2009) . In vitro differentiation of ESCs from embryoid bodies (EBs) generally recapitulates YS hematopoiesis, and efforts have been made to direct differentiation to produce transplantable HSCs by manipulating intrinsic or extrinsic signals (Ditadi et al., 2017) . Although not all types of progenitor cells can be produced from ESCs in vitro, the fact that developmental processes including EHT can be manipulated pharmacologically and genetically makes this system a valuable model to study how hematopoietic commitment occurs and can be influenced (Lancrin et al., 2009) .
Mll1 (Kmt2a) loss-of-function murine models implicated this gene as a major regulator of HSPC development and homeostasis including in EBs and embryos (Ernst et al., 2004a; Jude et al., 2007; McMahon et al., 2007; Yang and Ernst, 2017) . Our prior findings that MLL1 regulates an HSC-specific target gene repertoire led us to wonder whether increasing MLL1 levels could have an impact on hematopoietic development during the early waves of hematopoiesis. This question, however, has been difficult to address due to the absence of appropriate model systems.
The human MLL1/KMT2A gene is a frequent target of chromosomal translocations that cause acute leukemias (Krivtsov and Armstrong, 2007) . Most translocations produce fusions that exhibit ectopic transactivation capacity. However, partial tandem duplications within the MLL1 gene (MLL-PTD) and occasional cases of MLL1 amplification have been reported in myelodysplastic syndrome and acute myeloid leukemia (AML), often concomitant with upregulation of MLL1 target genes such as HOXA7, HOXA9, and MEIS1 (Dorrance et al., 2006; Poppe et al., 2004; Tang et al., 2015) . Attempts to determine the impact of these non-fusion events or to test the latent oncogenic potential of wild-type (WT) MLL1 protein have been hampered by the challenges of expressing the large MLL1 cDNA and the fact that MLL1 overexpression arrests cell growth (Joh et al., 1996; Liu et al., 2007) . Thus, having a model that enables increasing MLL1 levels would be of great significance for multiple mechanistic avenues of investigation. In the current study, we developed a system in which WT MLL1 can be induced within physiologically tolerated ranges. This system revealed that increasing MLL1 protein level only by $2-fold enhanced hematopoietic potential. These data also highlight the role of Rac/Rho/integrin signaling during the EHT.
RESULTS

Generation and Validation of WT hMLL1-Inducible ESCs
To achieve consistent and reversible induction of MLL1 in vitro and in vivo, we generated a doxycycline-inducible MLL1 human (hMLL1i) transgene by integrating a modified cDNA into the murine Col1a1 locus (Beard et al., 2006) (Figures S1A and S1B) . Human and mouse MLL1 proteins are 93% similar, and human fusion oncoproteins function in murine cells. Maximal induction of hMLL1 occurred at addition of 2 mg/mL doxycycline, which corresponded to an approximately 2-fold increase in total MLL1 protein ( Figures  1A, 1B , and S1C-S1E). To determine whether H3K4 methylation levels were altered by this increase, we performed western blots on extracted histones ( Figure S1F ). Consistent with prior results indicating that MLL1 is not a dominant H3K4 methyltransferase (Denissov et al., 2014; Mishra et al., 2014) , we found that H3K4me1/2/3 levels were not altered, despite significant changes in gene expression. Co-immunoprecipitation of Menin and Wdr5 demonstrated that induced MLL1 is functional and associates with known complex components (Figures S1G-S1I). Thus, we have developed a system in which physiologically tolerated induction of WT MLL1 can be achieved.
hMLL1 Induction Does Not Grossly Alter ESC Differentiation
To first determine whether increasing MLL1 protein influenced germ layer specification and differentiation, several regimens of induction were tested ( Figure S1J ). EBs generated from differentiated ESCs ± hMLL1 induction throughout the time course exhibited similar morphology and cell accumulation during differentiation ( Figures 1C and 1D ). This was true whether hMLL1 induction was performed throughout differentiation or during brief phases of differentiation (Figure 1D) . Genes characteristic of each of the three germ layers were expressed normally in all regimens ( Figures 1E-1G ). Thus, maximal hMLL1 induction does not grossly alter overall EB differentiation, cell survival, or proliferation.
Induction of hMLL1 Does Not Significantly Alter Mesoderm Differentiation
The production of hematopoietic cells in EBs occurs through developmental steps paralleling hematopoiesis in the YS of the embryo (Rowe et al., 2016) . Flk-1 expression encompasses mesodermal cells committed to hematopoietic, endothelial, cardiogenic, and muscle fates (Kattman et al., 2006; Lugus et al., 2009; Shalaby et al., 1997 ). In our system, Flk-1 + cells peak at day 4 of EB differentiation, and this is not altered by hMLL1 induction (Figure 2A ). Flk-1 + cells encompass both Pdgfra + and Pdgfra neg ; Flk1 + /Pdgfra + cells are cardiogenic, whereas Flk-1 + /Pdgfra neg cells contain precursors of endothelial and hematopoietic lineages (Kataoka et al., 2011) . Flk-1 + /Pdgfra neg cells give rise to a small population of HE cells that are Cd41 low /VE-cadherin + /Tie-2 + , which in turn differentiate into Cd41 hi /Cd45 + cells that include hematopoietic progenitor cells (Choi et al., 1998; Eilken et al., 2009; Kennedy et al., 2007; Lancrin et al., 2009; Robertson et al., 2000) . To test the impact of hMLL1 induction on this developmental progression, we induced hMLL1 during days 2-4 or days 4-7 and determined population frequencies by flow cytometry. hMLL1 induction did not alter Flk-1 + / Pdgfra neg cell generation ( Figure 2B ). HE cells (c-Kit + /Tie-2 + ) were produced in EBs with similar kinetics and in similar proportions except for a small reduction at day 7 in hMLL1-induced cultures ( Figures 2C, S2A , and S2B). Acquisition of hematopoietic markers (Cd41 hi /Cd45 + ) (Gritz and Hirschi, 2016) proceeded similarly regardless of hMLL1 induction ( Figure 2D ). These data show that overall specification of hemogenic endothelial precursors, as defined immunophenotypically, occurs independent of MLL1 levels.
Induction of hMLL1 Selectively Affects c-Kit + /Cd41 + Hematopoietic Progenitor Function
To determine whether the emergence of hematopoietic potential was influenced by hMLL1 induction, we determined c-Kit + /Cd41 + cell frequencies, which represent the first population enriched in multilineage hematopoietic colony forming units (CFU) in EBs (McKinney-Freeman et al., 2008) . None of the induction regimens altered the peak frequency or kinetics of c-Kit + /Cd41 + cell differentiation ( Figures 3A and S3A ). However, c-Kit + /Cd41 + cells sorted from hMLL1-induced EBs consistently produced 2-fold more CFU compared with controls ( Figure 3B ), which reflected a general increase in all colony types (Figures S3B and S3C) . This observation was consistent across two additional, independently targeted hMLL1-inducible clones ( Figure S3D ). Cells harvested at day 7 of the CFU assay exhibited similar surface phenotypes and morphologies ( Figures 3C and S3E ). The analogous embryo YS-derived EMPs lack B cell potential and are largely Cd16/32 + (Lacaud and Kouskoff, 2017; McGrath et al., 2015) , which are also features of our EB-derived EMP-like population ( Figure 3C and W.Y., unpublished data). Collectively, these data demonstrate that increasing MLL1 does not influence the production of EMP-like progenitors but selectively increases the hematopoietic potential of the population on a per cell basis.
To determine how hMLL1 induction increases hematopoietic potential, we first considered whether hMLL1 induction affected survival or proliferation of the newly generated EMP-like cells. Sorted day 6 c-Kit + /Cd41 + cells were briefly incubated with 5-bromo-2-deoxyuridine (BrdU) in liquid culture to quantify proliferation in control versus hMLL1-induced populations. No differences were observed in BrdU incorporation, cell-cycle phase (D) EB accumulation in different induction schemes. One representative from three independent experiments is shown. Data represent average cell numbers ± SEM, n = quadruplicate cultures. Experiments were performed with hMLL1-inducible ESCs. Dox 0-6 = doxycycline added to differentiation medium from day 0 to day 6; Dox 2-4, doxycycline added to differentiation medium from day 2 to day 4; Dox 4-6 = doxycycline added to differentiation medium from day 4 to day 6. (E-G) Representative gene expression of (E) mesoderm (Brachyury and Flk1), (F) ectoderm (Sox1 and Pax6), and (G) endoderm (Sox17 and Gata6) during EB differentiation. Experiments were performed with hMLL1inducible ESCs. PBS was the solvent control and Dox was added to differentiation medium from day 0 to 6. Data represent average expression (relative to Gapdh) ± SEM, n = 3 independent experiments. distribution ( Figure 3D ), or cells exhibiting sub-2N DNA content ( Figure 3E ). To investigate whether hMLL1 induction had an impact on self-renewal of this EMP-like population, we determined the serial replating capacity of c-Kit + /Cd41 + hematopoietic progenitors. The initial increase in CFU observed from the induced c-Kit + /Cd41 + population was not sustained upon serial replating (Figure 3F ), suggesting the MLL1-dependent increase in CFU occurred during the production of these EMP-like progenitors, rather than within the differentiating population in the CFU assay. Together, these data show that the MLL1responsive increase in CFU within the c-Kit + /Cd41 + was not explained by selective survival, proliferation, or increase in self-renewal.
To test the impact of MLL1 induction on hematopoietic development in vivo, we induced expression of hMLL1 in utero from conception ( Figure S3F ). At E9.5, the percentage of c-Kit + /Cd41 + progenitors in the YS was not affected by hMLL1 induction. However, these cells also produced more CFU on a per cell basis ( Figure 3G ), similar to the EB observation. We also enumerated hematopoietic cluster cells in the AGM using a whole-mount confocal microscopy technique (Yokomizo et al., 2012) . At E10.5, the appearance of c-Kit + /Cd31 + /Runx1 + clusters in the ventral wall of the dorsal aorta in the AGM region reflects the emergence of HSCs with definitive potential, whereas c-Kit neg / Cd31 + /Runx1 + cells in the same region reflect HE ( Single-Cell Sequencing Demonstrates that MLL1 Influences the Heterogeneity of the c-Kit + /Cd41 + Population Despite being the most enriched for hematopoietic potential, the EB day 6 c-Kit + /Cd41 + population is likely not homogeneously committed to the hematopoietic lineage. We hypothesized that MLL1 expression may influence cells within this population that respond to hematopoietic conditions of the CFU assay. We therefore analyzed day 6 c-Kit + /Cd41 + progenitors using single-cell RNA sequencing to determine (1) the heterogeneity of this EMP-like population and (2) whether MLL1 induction changes the composition of this population. Representative pools of sorted c-Kit + /Cd41 + cells from WT or hMLL1-induced day 6 EBs were subjected to single-cell sequencing ( Figure S4A ). Unsupervised clustering analysis using both WT and hMLL1induced progenitors suggested three unique populations within the c-Kit + /Cd41 + population ( Figures 4A, 4B , S4B, and S4C; the full gene list defining each cluster is shown in Table S1 ). Cluster 1 (green) was enriched in myeloid and innate immune cell-associated genes such as Ly6e, Ccl3, Fcer1g, Tyrobp, and Cd52 ( Figure S4D and Table S1 ) and enriched the terms ''immune system process'' and ''myeloid leukocyte differentiation'' ( Figure S4E and Table  S1 ). Cluster 2 (red) was defined by erythroid specific genes such as Klf1, Gata1, Hbb-bh1 and enriched the term ''erythrocyte differentiation'' (Figures S4D and S4E and Table S1 ). Interestingly, cluster 3 (blue, ''HE-like'') retained the expression of many endothelial genes, suggesting recent emergence from HE (e.g. Esam, Cdh5, Tie1, Kdr) and enriched the terms ''vasculature development'' and ''regulation of angiogenesis'' ( Figures S4D and S4E and Table S1 ). In silico cell-cycle analysis showed a similar distribution and percentage of S/G 2 /M cells within all populations, corroborating our proliferation studies ( Figure S4F ). This cellular heterogeneity is very similar to that observed in the parallel E9.5 embryo YS c-Kit + /Cd41 + /Cd16/32 + population (Kathleen McGrath, Jacquelyn Lillis, and James Palis, personal communication).
To examine the impact of hMLL1 on the distribution of cell types within the c-Kit + /Cd41 + population, we plotted the percentage of each of the three defined clusters in WT versus hMLL1-induced populations ( Figure 4C ). This analysis showed an increase in myeloid and erythroid populations at the expense of the HE-like population ( Figure 4C ). We also examined the developmental trajectories of WT and hMLL1-induced samples. Pseudotime analysis with either WT or hMLL1-induced EB progenitors placed the HE-like cluster as a precursor for both erythroid and myeloid/innate immune clusters ( Figures 4D and S4G) . Collectively, these results suggest that hMLL1 induction reshapes the composition of the c-Kit + /Cd41 + progenitor pool to contain a greater proportion of erythroid-and myeloid-oriented progenitors that may be primed for generating hematopoietic colonies in the CFU assay. Table S1 ). The top 15 (clusters 1 and 2) or top 37 (cluster 3) genes enriched in each cluster are shown in a heatmap with gene expression represented on a log scale from red to blue (high to low).
(legend continued on next page)
Enhanced Rac/Rho/Integrin Signaling Is a Major Feature of hMLL1-Induced c-Kit + /Cd41 + Progenitors To understand the mechanisms by which MLL1 induction altered cell fate during hematopoietic progenitor development, we focused on the ''HE-like'' (cluster 3) cells, since they likely represented the earliest stage of differentiation affected by hMLL1 induction (Figure 4D ). Differentially expressed genes comparing WT versus hMLL1-induced cluster 3 cells were identified and subjected to ingenuity pathway analysis (IPA). This approach showed induction of several canonical signaling pathways in the hMLL1induced samples, for example ''Rac signaling,'' ''integrin signaling,'' and ''RhoGDI signaling'' ( Figure S5A ). To confirm and extend these analyses, we performed bulk RNA sequencing using three independently sorted c-Kit + / Cd41 + populations from WT or hMLL1-induced EBs. Principal component analysis indicated that the hMLL1induced samples cluster by genotype ( Figure S5B ). Again, IPA analysis using differentially expressed genes from the entire c-Kit + /Cd41 + population recapitulated the results from the single-cell HE-like cluster analysis, showing most significant enrichment of the canonical pathways ''Rac signaling,'' ''Rho GTPase signaling,'' ''integrin signaling,'' and ''actin cytoskeleton signaling'' ( Figures 5A  and S5C ). These signaling annotations share many genes in common (Lie et al., 2014) ( Figure 5B ). We confirmed and extended these results using independently sorted samples, including integrins (Itgb2, Itgal, Itga4), Rac/Rho small GTPases (Rac1, Rac2, Rhoa), kinases (Akt1, Pi3kcd), regulatory subunits or cytoskeleton proteins (Myl12a/b, Actb, Arp3) ( Figures 5C and S5D ). Immunofluorescence staining of F-actin showed increased spontaneous cell spreading in hMLL1-induced Cd41-enriched progenitors when incubated on fibronectin, suggesting enhanced propensity for re-organization of actin filaments upon adhesion ( Figure 5D ). Together, these results demonstrate that hMLL1 induction activates a Rac/Rho/integrin cellular signaling state and enhances integrin-mediated adhesion and cytoskeletal rearrangement.
hMLL1 Induction Specifically Promotes Integrin-Mediated Cell Adhesion, Increasing Hematopoietic Potential
To test the functional impact of enhanced Rac/Rho/integrin signaling pathways, we first tested cell-surface expression of candidate integrins. Among all MLL1-induced candidates from RNA sequencing analysis, we only observed a significant increase in the percentage of Cd49d+ (encoded by Itga4, a subunit of Vla4) cells within the c-Kit + /Cd41 + day 6 EB cell population ( Figure 6A ). Surface expression of the other subunit of Vla4, Cd29 (encoded by Itgb1) and other expressed integrins (Cd11a, encoded by ItgaL; Cd18, encoded by Itgb2) did not change upon hMLL1 induction ( Figure S6A ). To test whether hMLL1-induced progenitors exhibited an increase in an integrin-mediated function, we allowed cells to adhere to the integrin ligand-coated surfaces and tested baseline adhesion and the effect on hematopoietic potential ( Figure 6B ). hMLL1induced progenitors consistently exhibited increased adhesion to the Vla4 ligands fibronectin and Vcam1 relative to control progenitors ( Figure 6C ). This observation was reproduced with additional independent hMLL1-inducible ESC clones ( Figure S6B ). To investigate the functional outcome of engaging Vla4, we cultured Cd41-enriched progenitors on fibronectin-coated wells for 24 h then transferred all cells to the CFU assay ( Figure 6D ). Although fibronectin binding did not influence the CFU of WT cells, it further increased CFUs from hMLL1-induced cells ( Figures  6D and S6C) . To test if this MLL1-dependent CFU increase occurs through Rac-mediated signaling, we treated hMLL1induced cells briefly with a Rac1 specific inhibitor (NSC23766) and then performed CFU assays. While WT cells did not exhibit changes in CFU frequency, use of the Rac inhibitor on hMLL1-induced cells significantly decreased CFU frequencies, bringing them back to levels observed in WT untreated cells ( Figures 6D and S6D) . These data collectively suggest that the enhanced signaling state produced by hMLL1 induction is Rac1-dependent and increases responsiveness to Vla4 ligands, resulting in enhanced hematopoietic commitment from the transitional c-Kit + /Cd41 + population.
DISCUSSION
Here, we present a model system in which increasing MLL1 protein levels within a physiologically reasonable range can be achieved and show that this perturbation selectively increases hematopoietic potential during a transition from endothelial to hematopoietic fate. The approach used here has been very useful for testing the effect of consistent and physiologic overexpression of several transcription factors including Scl, Cdx4, Hoxb4, Mix1, and Notch1 (Ismailoglu et al., 2008; Kubo et al., 2005 ; Kyba 
Itgb2
Itgal Itga4
Rac1
Rac2 Rhoa Akt1 Actb Arp3
WT hMLL1i
Relative expression min max WT 1 WT 2 WT 3 hMLL1i 1 hMLL1i 2 hMLL1i 3 , 2002; McKinney-Freeman et al., 2008; Meier-Stiegen et al., 2010; Wang et al., 2005; Willey et al., 2006) . In contrast to the effect of hMLL1 induction, Cdx4 or Hoxb4 overexpression increases c-Kit + /Cd41 + hematopoietic progenitors at an earlier stage, promoting formation of HE and subsequently, hematopoietic potential (Teichweyde et al., 2018; Wang et al., 2005) . While inducing hMLL1 apparently does not numerically affect HE or increase c-Kit + /Cd41 + progenitors, it reshapes the composition of this population, resulting in enhanced hematopoietic potential. Interestingly, we also observe an increase in hematopoietic clusters from HE in the dorsa aorta of hMLL1-induced E10.5 embryos, suggesting that hMLL1 plays a parallel role in a distinct hemogenic endothelial site in vivo. The specific impact of MLL1 induction may be due to the regulation of a yet undefined network regulating Rac1 activity, integrin-mediated adhesion, and cytoskeletal rearrangement during the EHT process.
DAPI F-Actin
The application of single-cell RNA sequencing in this setting enabled us to investigate the heterogeneity of a murine EB-derived EMP-like hematopoietic progenitor pool, which has not yet been addressed. Comparative analysis of our in vitro day 6 c-Kit + /Cd41 + EMP-like progenitor with the E9.5 in vivo YS EMP (McGrath et al., 2015) single-cell sequencing data showed a very similar composition, including a residual HE-like population, an erythroid and a myeloid/innate immune population (Kathleen McGrath, Jacquelyn Lillis, and James Palis, personal communication). The similarities in transcriptome-defined populations in vivo and in vitro underscore the relevance of the ESC system for dissecting sequential developmental stages of hematopoiesis. The presence of a residual HE-like gene expression signature is consistent with the observation that the onset of hematopoietic potential commences with Cd41 expression within a hemogenic endothelial population (Lancrin et al., 2009; McGrath et al., 2015) , thus the c-Kit + /Cd41 + population likely represents an asynchronous pool of cells with varying degrees of ''memory'' of hemogenic endothelial identity. We interpret the single-cell transcriptome data to suggest that hMLL1 induction alters the composition of the EMP-like progenitor pool, resulting in either more efficient commitment to the hematopoietic lineages at the expense of the HE-like population, or that hMLL1 induction accelerated kinetics of departure from an HE-like state toward the myeloidand erythroid-primed progenitors. Given our observations that hMLL1 induction does not increase the c-Kit + /Cd41 + population, as well as the similarity of the kinetics devel-oping hemogenic populations, it seems more likely that hMLL1 induction promotes hematopoiesis by driving more efficient commitment to multilineage hematopoietic fates.
A very surprising finding was the fact that hMLL1 induction did not affect Hox cluster gene expression. The generally low expression levels of Hoxa-d clusters in EB-derived hematopoietic progenitors has been noted by others (Dou et al., 2016; Ng et al., 2016) . This feature of EB-derived and YS-derived progenitors may underlie their inability to generate definitive HSCs since the parallel or immunophenotypically similar fetal liver progenitors can express much higher Hox levels (Dou et al., 2016) . We speculate that the acquisition of a Hoxa signature may need additional sequence-specific transcriptional inputs (e.g., retinoic acid signaling) (Dou et al., 2016) , while MLL1 itself is not capable of such induction, consistent with the role of Trithorax as a maintenance factor rather than inducer of gene expression (Schuettengruber et al., 2011) . In fact, preliminary data suggest that Hoxa induction by retinoic acid receptor agonists is sustained more efficiently in the presence of induced hMLL1 (W.Y., unpublished data).
Interestingly, induction of hMLL1 does not lead to leukemic transformation as with MLL fusion oncoproteins in other cellular settings. Recent work by Bueno et al. demonstrates that ectopic expression of MLL-AF4 is not sufficient to induce leukemic transformation in human ESC-derived hematopoietic cells (Bueno et al., 2012 (Bueno et al., , 2019 , consistent with our observation that inducing MLL-ENL does not transform ES-derived hematopoietic progenitors (W.Y. and D.B., unpublished data). These findings raise questions about the responsiveness of EMP-like populations to transformation, specifically by oncogenes that may require induction of a Hox program. The lack of or limited Hox induction in hMLL1-induced cultures or the distinct dynamic pattern (Spencer et al., 2015; Zeisig et al., 2004) in MLL fusion transduced EBs may represent a hurdle that restrains cell growth or transformation. Overcoming this hurdle may require developmental context and Hox regulators in addition to MLL1. Defining exact window of development and mechanisms of Hox locus responsiveness may shed light on the cell of origin and pediatric association of MLL1 translocations (Barrett et al., 2016) .
In this study, we identified Rac/Rho/integrin signaling as a major axis activated by hMLL1 induction within the EMPlike population of developing EBs. hMLL1 induction resulted in increased Itga4, Itgal, and Itgb2 transcripts and fragment and then followed by CFU assay. One representative experiment of three is shown as the average ± SEM, n = 3 triplicate cultures. Right: quantification of CFU fold changes with Dox, fibronectin fragment, or Rac1 inhibitor (NSC23766, 10 mM). The graph show data pooled from 3 to 4 independent experiments (n = 3 for WT; n = 4 for hMLL1i, with each data point representing the average of triplicate cultures) representing the overall average ± SEM.
increased Cd49d surface expression. hMLL1 induction also promotes integrin-mediated cell adhesion and further activation of integrin signaling through Vla4, resulting in enhanced CFU from this EMP-like population. Several previous studies have implicated the Rac/Rho/integrin axis as limiting for hematopoietic development and homeostasis. First, the Cd49d + fraction of ESC-derived endothelium is enriched in both primitive and definitive hematopoietic progenitor activity (Shinoda et al., 2007) . Second, Rac1 activation during early embryonic hematopoiesis in the dorsal aorta, as well as Rac2 and Cdc42 activation in Lin neg / c-Kit + /Sca-1 + HSPCs, is associated with Vla4-mediated adhesion, migration, engraftment, and survival of HSPCs (Ghiaur et al., 2008; Yang et al., 2001) . Interestingly, studies identifying Runx1 target genes in hemogenic endothelia of the embryo or in EBs also revealed integrin signaling, Rho signaling, cytoskeletal organization, and cell adhesion as enriched pathways regulated by Runx1 (Gao et al., 2018; Lie et al., 2014) . The effect of Runx1 induction has been proposed to be in part through direct regulation of the integrin Cd61 (Itgb3) (Lie et al., 2014) . The cause of widespread Rac/ Rho activation in hMLL1-induced EMP-like progenitors is unclear but may reflect a complex combination of direct and indirect effects of increasing MLL1 levels. Since we observe downregulation of several RhoGEFs, it is also possible that compensatory upregulation of the Rac/Rho pathways results in the more active adhesion phenotype in MLL1-induced progenitors and could account for the greater number of hematopoietic cells in the aortic clusters. Collectively, our data underscore the impact of integrin/Rac/ Rho signaling in the EHT process, and that Runx1 and MLL1 may both regulate this critical step in parallel.
In summary, utilizing this physiologic MLL1-inducible model system revealed an unanticipated connection between MLL1 and integrin-mediated signaling that appears to enhance the efficiency of EHT. Whether these pathways are conserved in the later waves of hematopoiesis in the embryo and adult, and whether they can collaborate with other signals for more efficient production of HSPCs, will be important future questions.
EXPERIMENTAL PROCEDURES
ESC Culture and Differentiation
ESCs were maintained on embryonic fibroblasts using standard conditions (Ernst et al., 2004b) . For in vitro differentiation, single-cell suspensions from dissociated ESC cultures were seeded at 10,000-20,000 cells/mL in Petri dishes (Fisher) with orbital rotation (50 rpm, Labnet Orbit 1000). The differentiation medium was Iscove's modified Dulbecco's medium (Mediatech) containing 15% fetal bovine serum (Gibco), 2 mM L-glutamine (Mediatech), 1% penicillin/streptomycin (Mediatech), 200 mg/mL holo bovine transferrin (Millipore), 4.5 3 10 À4 M monothioglycerol (Sigma) and 50 mg/mL ascorbic acid (Sigma). Doxycycline (Enzo Life Sciences) was added to the differentiation medium at 1-2 mg/mL for the times indicated in each figure legend.
Flow Cytometry, Cell Isolation, and Sorting
EBs were dissociated with collagenase (0.8 U/mL, Sigma) and dispase I (2 mg/mL, Sigma) and then incubated with the indicated antibodies (Biolegend or eBiosciences). Stained cells were analyzed or sorted using an LSR Fortessa or FACSAria Fusion, respectively (BD Biosciences). Gating was based on either single color or isotype control staining. Enrichment was performed using Miltenyi Cd41 magnetic beads. Flow cytometry data were analyzed using FlowJo software (TreeStar).
Single-Cell Sequencing, RNA Sequencing, and Bioinformatics
Single-cell RNA sequencing was performed with singlet-gated, DAPInegative, c-Kit + /Cd41 + cells from day 6 EBs sorted using a FACSAria Fusion. Cell purity was determined by post-sort re-analysis and was typically >90% ( Figure S4A ). Approximately 4,000 sorted cells were used to generate libraries and sequenced by the University of Colorado Cancer Center Genomics and Microarray core facility. Bulk RNA sequencing was performed using sorted c-Kit + /Cd41 + pools of cells from WT (KH2) or hMLL1-inducible EBs incubated with doxycycline from day 4 to day 6. Three separate differentiation experiments were performed with WT (KH2) and hMLL1i differentiated in parallel. Detailed sequencing data analysis and methods can be found in Supplemental Experimental Procedures.
Statistical Analyses
Significance was analyzed in all studies using unpaired Student's t tests and standard error of the mean (SEM) with *p < 0.05, **p < 0.01, ***p < 0.001 considered significant unless otherwise indicated in the figure legends. GraphPad Prism or Microsoft Excel software was used to perform the statistical calculations.
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